Shield Bio Overview
- Year Founded
-
2016
- Status
-
Out of Business
- Employees
-
28
- Latest Deal Type
-
Out of Business
Shield Bio General Information
Description
Developer of a susceptibility testing platform designed to ensure the effectiveness of antibiotics. The company develops rapid and accurate molecular antibiotic susceptibility testing for those infections which pose the greatest threat of acquiring total antibiotic resistance, enabling physicians to identify infectious agents and genes associated with susceptibility and enhance accuracy and sensitivity to enable better patient treatment from the start.
Contact Information
Website
www.shieldbio.comCorporate Office
- 2865 Zanker Road
- San Jose, CA 95134
- United States
Corporate Office
- 2865 Zanker Road
- San Jose, CA 95134
- United States
Shield Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Out of Business | 23-Nov-2021 | Completed | Out of Business | |||
| 8. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 7. Early Stage VC (Series B2) | 27-Feb-2020 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 5. Early Stage VC | 26-Jun-2019 | Completed | Generating Revenue | |||
| 4. Debt - General | 15-Aug-2018 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 24-May-2018 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jun-2016 | $120K | $3.12M | Completed | Startup | |
| 1. Seed Round | 01-Jan-2016 | $3M | $3M | Completed | Startup |
Shield Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 | ||||||||
| Series A1 | ||||||||
| Seed 4 | ||||||||
| Seed 3 | ||||||||
| Seed 2 | 589,218 | $0.000010 | $0.03 | $0.45 | $0.45 | 1x | $0.45 | 1.97% |
| Seed 1 | 112,296 | $0.000010 | $0.05 | $0.89 | $0.89 | 1x | $0.89 | 0.38% |
Shield Bio Comparisons
Industry
Financing
Details
Shield Bio Competitors (2)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Karius | Venture Capital-Backed | Redwood City, CA | ||||
| Day Zero Diagnostics | Venture Capital-Backed | Boston, MA |
Shield Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Shield Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Shield Bio FAQs
-
When was Shield Bio founded?
Shield Bio was founded in 2016.
-
Who is the founder of Shield Bio?
Fred Turner and Sam Parlett are the founders of Shield Bio.
-
Where is Shield Bio headquartered?
Shield Bio is headquartered in San Jose, CA.
-
What is the size of Shield Bio?
Shield Bio has 28 total employees.
-
What industry is Shield Bio in?
Shield Bio’s primary industry is Other Healthcare Technology Systems.
-
Is Shield Bio a private or public company?
Shield Bio is a Private company.
-
What is Shield Bio’s current revenue?
The current revenue for Shield Bio is .
-
How much funding has Shield Bio raised over time?
Shield Bio has raised $13.2M.
-
Who are Shield Bio’s competitors?
Karius and Day Zero Diagnostics are competitors of Shield Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
